1. The role of the TNF-α gene −308 G/A polymorphism in the development of diabetic nephropathy: An updated meta-analysis.
- Author
-
Tiongco, Raphael Enrique, Aguas, Imoan Shallom, Cabrera, Franzielle Jowe, Catacata, Miljun, Flake, Chastene Christopher, Manao, Maria Angelica, and Policarpio, Archie
- Abstract
Several studies have tried to link the relationship of tissue necrosis factor-alpha (TNF-α) −308 G/A polymorphism with the development of diabetic nephropathy (DN). However, these studies failed to reach a consensus due to conflicting results. This meta-analysis was done to thoroughly investigate the correlation between the polymorphism and DN development. To carry out the objective, patients with type 2 diabetes mellitus (T2DM) were used as controls, while patients who developed DN were utilized as cases. Eight studies (i.e., published between 2007 and 2018) were included in the present meta-analysis. Review Manager 5.3 was used to compute for the odds ratios (OR) and 95% confidence interval (CI) of the overall and post-outlier outcomes. Overall, an association between DN development and the −308 G/A polymorphism was observed. However, Galbraith's plot analysis (as analyzed using Meta-Essentials) led to the removal of two studies, which significantly reduced heterogeneity. Post-outlier outcomes show significant results in the allelic (OR: 1.23; 95% CI: 1.01–1.50; p = 0.04) and co-dominant (OR: 1.60; 95% CI: 1.02–2.51; p = 0.04) models. T2DM individuals with the −308 G/A polymorphism in the TNF-α gene are more likely to develop DN. • Eight studies were included to assess the association of the −308 G/A polymorphism with diabetic nephropathy development. • The −308 G/A polymorphism is associated with diabetic nephropathy development among individuals with type 2 diabetes. • People with type 2 diabetes having the A allele and AA genotype have an increased likelihood of developing nephropathy. • ABSTRACT. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF